| 摘要 |
PROBLEM TO BE SOLVED: To provide a skin aging inhibitor for inhibiting skin aging, particularly flabbiness, associated with the reduction in female hormone relating to ovarian dysfunction, particularly the reduction in female hormone due to menopause. SOLUTION: This skin aging inhibitor comprises a matrix metalloprotease inhibitor as the active ingredient. This inhibitor is effective for inhibiting skin aging associated with the reduction in female hormone relating to ovarian dysfunction.
|
